Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A North

Showing results (481-490 of 501) with videos related to

Pageof 51
Sort By:
Structure (London, England : 1993)|November 6, 2025
Structural basis of isethionate transport by a TRAP transporter from a sulfate-reducing bacteriumMichael C Newton-Vesty, Mariafrancesca Scalise, Sam A Jamieson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2022
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapyJeffrey Graham, John Connor Wells, Shaan Dudani, et al.
The Lancet. Oncology|November 13, 2012
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trialChristopher J Logothetis, Ethan Basch, Arturo Molina, et al.
Clinical Genitourinary Cancer|December 3, 2014
Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database ConsortiumAndré P Fay, Wanling L Xie, Jae-Lyn Lee, et al.
Elife|February 13, 2024
Structural and biophysical analysis of a <i>Haemophilus influenzae</i> tripartite ATP-independent periplasmic (TRAP) transporterMichael J Currie, James S Davies, Mariafrancesca Scalise, et al.
Clinical Genitourinary Cancer|December 3, 2014
Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumChristos E Kyriakopoulos, Namita Chittoria, Toni K Choueiri, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A Bjarnason, Jennifer J Knox, Christian K Kollmannsberger, et al.
European Urology|August 7, 2013
Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapyNils Kroeger, Toni K Choueiri, Jae-Lyn Lee, et al.
Cancer|May 23, 2013
Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteriaNils Kroeger, Wanling Xie, Jae-Lyn Lee, et al.
Nature Communications|February 28, 2023
Structure and mechanism of a tripartite ATP-independent periplasmic TRAP transporterJames S Davies, Michael J Currie, Rachel A North, et al.
Pageof 51

Showing results (481-490 of 501) with videos related to

Sort By:
Pageof 51
Structure (London, England : 1993)|November 6, 2025
Structural basis of isethionate transport by a TRAP transporter from a sulfate-reducing bacteriumMichael C Newton-Vesty, Mariafrancesca Scalise, Sam A Jamieson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2022
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapyJeffrey Graham, John Connor Wells, Shaan Dudani, et al.
The Lancet. Oncology|November 13, 2012
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trialChristopher J Logothetis, Ethan Basch, Arturo Molina, et al.
Clinical Genitourinary Cancer|December 3, 2014
Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database ConsortiumAndré P Fay, Wanling L Xie, Jae-Lyn Lee, et al.
Elife|February 13, 2024
Structural and biophysical analysis of a <i>Haemophilus influenzae</i> tripartite ATP-independent periplasmic (TRAP) transporterMichael J Currie, James S Davies, Mariafrancesca Scalise, et al.
Clinical Genitourinary Cancer|December 3, 2014
Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumChristos E Kyriakopoulos, Namita Chittoria, Toni K Choueiri, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A Bjarnason, Jennifer J Knox, Christian K Kollmannsberger, et al.
European Urology|August 7, 2013
Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapyNils Kroeger, Toni K Choueiri, Jae-Lyn Lee, et al.
Cancer|May 23, 2013
Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteriaNils Kroeger, Wanling Xie, Jae-Lyn Lee, et al.
Nature Communications|February 28, 2023
Structure and mechanism of a tripartite ATP-independent periplasmic TRAP transporterJames S Davies, Michael J Currie, Rachel A North, et al.
Pageof 51